O&d Biotech Group Co., Limited

This is an early-stage study testing a new type of cell therapy called O&D-001 for adults with multiple myeloma that has come back or stopped responding to standard treatments. The therapy involves modifying a patient's own immune cells to recognize and attack two specific target…